8-K: Astera Labs Appoints Dr. Craig Barratt to Board of Directors, Expanding Board to Eight Members

Astera Labs appoints Dr. Craig Barratt to its Board of Directors, increasing the board size and adding expertise in scaling high-growth technology companies.

Summary

• Astera Labs has appointed Dr. Craig Barratt to its Board of Directors, effective March 2, 2025.
• The Board size was increased from seven to eight members.
• Dr. Barratt will also replace Manuel Alba on the Audit Committee.
• He is deemed an independent director according to Nasdaq listing rules.
• Dr. Barratt will stand for election at the company's 2026 Annual Meeting of Stockholders.
• He has a strong background in the technology industry, including roles at Intel, Google, Qualcomm, and Atheros Communications.
• Dr. Barratt will receive an annual retainer of $60,000 for Board service and $12,500 for Audit Committee service, prorated for 2025.
• He will also be granted a one-time restricted stock unit (RSU) award with a fair market value of $330,000, vesting over three years.
• Dr. Barratt will enter into the company's standard indemnification agreement.

Sentiment

Score: 8

Explanation: The announcement is positive due to the addition of an experienced and well-regarded director to the board. This is likely to be viewed favorably by investors.

Positives

• The appointment of Dr. Barratt brings significant experience and expertise to the Astera Labs Board.
• His background in scaling high-growth technology companies is expected to be valuable to Astera Labs.
• Dr. Barratt's experience at companies like Intel, Google, and Qualcomm provides him with a broad perspective on the technology industry.
• The compensation package for Dr. Barratt is in line with the company's customary arrangements for non-employee directors.

Future Outlook

Astera Labs anticipates that Dr. Barratt's expertise will provide critical guidance as they continue to expand their leadership in connectivity solutions for AI and cloud infrastructure.

Management Comments

• Jitendra Mohan, CEO and Co-founder of Astera Labs, stated that Dr. Barratt's track record makes him an invaluable addition to the Board and that his strategic insight and deep technical expertise will provide critical guidance.
• Manuel Alba, Chairman of the Board, stated that Dr. Barratt's experience and strategic vision will be instrumental in helping to steer Astera Labs as they continue their rapid growth and innovation in AI connectivity.
• Dr. Craig Barratt stated he is excited to join the Board and collaborate with the team to support the company's strong momentum and strengthen its industry leadership.

Industry Context

The appointment of Dr. Barratt, with his extensive experience in the semiconductor and networking industries, aligns with Astera Labs' focus on providing connectivity solutions for AI and cloud infrastructure, which are rapidly growing sectors.

Comparison to Industry Standards

• Dr. Barratt's previous roles at Intel, Google, and Qualcomm provide him with experience comparable to leaders at other major technology companies.
• His board experience at Intuitive Surgical, Inc. and IonQ, Inc. is similar to that of directors at other publicly traded companies.
• The compensation package offered to Dr. Barratt is consistent with industry standards for non-employee directors at companies of similar size and stage.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of Dr. Barratt positively, as it brings additional expertise and experience to the Board.
• Employees may be encouraged by the company's ability to attract high-caliber talent to its leadership team.

Key Dates